Guengerich FP. Biotransformation, Vol. 3, Compr Toxicology, first ed. Elsevier
Science, Oxford; 1997.
Guengerich FP. Human cytochrome P-450 3A4: regulation and role in drug meta-
bolism. Annu Rev Pharmacol Toxicol 1999;39:l–17.
Guengerich FP. Common and uncommon cytochrome P450 reactions related to
metabolism and chemical toxicity. Chem Res Toxicol 2001;14:611–650.
Guengerich FP. Cytochrome P450 oxidations in the generation of reactive electrophiles:
epoxidations and related reactions. Arch Biochem Biophys 2003;409:59–71.
Guengerich FP. Human cytochrome P450 enzymes, In: Ortiz de Montellano PR,
editor. Cytochrome P450: Structure, Mechanism, and Biochemistry, third ed. Kluwer
Academic/Plenum Publishers; New York: 2005. p 377–531.
Guengerich FP, Macdonald TL. Chemical mechanisms of catalysis by cytochromes
P-450: a unified view. Acc Chem Res 1984;17:9–16.
Guengerich FP, Cai H, McMahon M, Hayes JD, Sutter TR, Groopman JD, Deng Z,
Harris TM. Reduction of aflatoxin B, dialdehyde by rat and human aldo–keto
reductases. Chem Res Toxicol 2001;14:727–737.
Guengerich FP, Wu Z-L, Bartleson CJ. Function of human cytochrome P450s: characteri-
zation of the remaining orphans. Biochem Biophys Res Commun 2005;338:465–469.
Hammock BD, Grant DF, Storms DH. Epoxide hydrolases. In: Guengerich FP, editor.
Biotransforrnation, Vol. 3, Comprehensive Toxicology, first ed. Elsevier Science,
Oxford; 1997. p 283–305.
Hayashi Y, Yamazaki I. The oxidation-reduction potentials of compound I/compound
II and compound II/ferric couples of horseradish peroxidases A2 and C. J Biol Chem
1979;254:9101–9106.
Huang M-T, Miwa GT, Cronheim N, Lu AYH. Rat liver cytosolic azoreductase.
Electron transport properties and the mechanism of dicoumarol inhibition of the
purified enzyme. J Biol Chem 1979;254:11223–11227.
Jaiswal AK. Human NAD(P)H-quinone oxidoredutase. Gene structure, activity, and
tissue-specific expression. J Biol Chem 1994;269:14502–14508.
Jez JM, Flynn TG, Penning TM. A new nomenclature for the aldo–keto reductase
superfamily. Biochem Pharmacol 1997;54:639–647.
Johnson WW, Ueng Y-F, Yamazaki H, Shimada T, Guengerich FP. Role of
microsomal epoxide hydrolase in the hydrolysis of aflatoxin B 1 8,9-epoxide. Chem
Res Toxicol 1997;10:672–676.
Josephy PD, Guengerich FP, Miners JO. Phase 1 and phase 2 drug metabolism:
terminology that we should phase out. Drug Metab Dispos 2005;37:579–584.
Kalgutkar AS, Gardner I, Obach RS, Shjaffer CL, Callegari E, Henne KR, Mutlib AE,
Dalvie DK, Jee JS, Nakai Y, O’Donnell JP, Boer, Harriman SP. A comprehensive
listing of bioactivation pathways of organic functional groups. Curr Drug Metab
2005;6:161–225.
Ketterer B, Meyer DJ. Glutathione transferases: a possible role in the detoxication and
repair of DNA and lipid hydroperoxides. Mut Res 1989;214:33–40.
Kim D, Kadlubar FF, Teitel CH, Guengerich FP. Formation and reduction of aryl and
heterocyclic nitroso compounds and significance in the flux of hydroxylamines.
Chem Res Toxicol 2004;17:529–536.
REFERENCES 33